Skip to content
Screener

Guardian Pharmacy Services GRDN Q4 2025 Annual earnings

Reported March 11, 2026 · After market close

Revenue$397.6MBeat by $7.6M
EPS$0.37Beat by $0.10
Revenue estimate$390.0M
EPS estimate$0.27

Next report

Date not yet announced

Financials

Q4 2025

Income statement

See full
Revenue$397.6M+17.4%
Gross profit$85.5M+27.4%
Operating income$30.8M—
Net income$20.9M—
EPS (diluted)$0.33—

Balance sheet

See full
Cash & equivalents$65.6M+1,308%
Total debt$44.7M+19.8%
Total equity$217.9M+45.3%
Total assets$412.7M+28.6%

Cash flow

See full
Operating cash flow$34.6M+54.9%
CapEx$495.0K-78.0%
Free cash flow$34.1M+69.8%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.91B+48.6%
Enterprise value$1.88B+43.3%
P/E38.7×—
P/S1.3×+0.3×

Profitability

See full
Gross margin20.2%+0.3pp
Operating margin5%—
Net margin3.4%+2.0pp

Returns & leverage

See full
Return on equity26.8%—
Debt / equity0.2×0.0×
Current ratio1.4×+0.3×

Segments

By segment

See full
Corporate$397.6M+17.4%

FAQ

When did Guardian Pharmacy Services report Q4 2025 earnings?
Guardian Pharmacy Services (GRDN) reported Q4 2025 earnings on March 11, 2026 after market close.
What were Guardian Pharmacy Services's Q4 2025 revenue and EPS?
Guardian Pharmacy Services reported revenue of $397.6M and eps of $0.37 for Q4 2025.
Did Guardian Pharmacy Services beat estimates in Q4 2025?
Revenue beat the consensus estimate of $390.0M by $7.6M. EPS beat the consensus estimate of $0.27 by $0.10.
How did Guardian Pharmacy Services's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 17.4% from $338.6M a year earlier and eps grew 54.2% from $0.24.
Where can I find Guardian Pharmacy Services's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-102153) and the 10-K periodic report (0001193125-26-102172) directly on SEC EDGAR. The filing index links above go to sec.gov.